title: The RNA binding protein HuR does not interact directly with HIV-1 reverse transcriptase and does not affect reverse transcription in vitro.
abstract: BACKGROUND
  Lemay et al recently reported that the RNA binding protein HuR directly interacts with the ribonuclease H (RNase H) domain of HIV-1 reverse transcriptase (RT) and influences the efficiency of viral reverse transcription (Lemay et al., 2008, Retrovirology 5:47). HuR is a member of the embryonic lethal abnormal vision protein family and contains 3 RNA recognition motifs (RRMs) that bind AU-rich elements (AREs). To define the structural determinants of the HuR-RT interaction and to elucidate the mechanism(s) by which HuR influences HIV-1 reverse transcription activity in vitro, we cloned and purified full-length HuR as well as three additional protein constructs that contained the N-terminal and internal RRMs, the internal and C-terminal RRMs, or the C-terminal RRM only.
  
  
  RESULTS
  All four HuR proteins were purified and characterized by biophysical methods. They are well structured and exist as monomers in solution. No direct protein-protein interaction between HuR and HIV-1 RT was detected using NMR titrations with 15N labeled HuR variants or the 15N labeled RNase H domain of HIV-1 RT. Furthermore, HuR did not significantly affect the kinetics of HIV-1 reverse transcription in vitro, even on RNA templates that contain AREs.
  
  
  CONCLUSIONS
  Our results suggest that HuR does not impact HIV-1 replication through a direct protein-protein interaction with the viral RT.
authors.affiliation: Department of Structural Biology, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA. jia12@pitt.edu
authors.forename: Jinwoo
authors.initials: J
authors.lastname: Ahn
authors.forename: In-Ja L
authors.initials: IJ
authors.lastname: Byeon
authors.forename: Sanjeewa
authors.initials: S
authors.lastname: Dharmasena
authors.forename: Kelly
authors.initials: K
authors.lastname: Huber
authors.forename: Jason
authors.initials: J
authors.lastname: Concel
authors.forename: Angela M
authors.initials: AM
authors.lastname: Gronenborn
authors.forename: Nicolas
authors.initials: N
authors.lastname: Sluis-Cremer
mesh_terms: D000954:Antigens, Surface / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism*; D003001:Cloning, Molecular; D051959:ELAV Proteins; D000067780:ELAV-Like Protein 1; D054303:HIV Reverse Transcriptase / Q000378:metabolism*; D015497:HIV-1 / Q000502:physiology*; D006801:Humans; D019906:Nuclear Magnetic Resonance, Biomolecular; D025941:Protein Interaction Mapping; D055503:Protein Multimerization; D012367:RNA, Viral / Q000378:metabolism*; D016601:RNA-Binding Proteins / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism*; D011994:Recombinant Proteins / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism; D048348:Reverse Transcription
chemical_list: D000954:Antigens, Surface; D051959:ELAV Proteins; D000067780:ELAV-Like Protein 1; C098770:ELAVL1 protein, human; D012367:RNA, Viral; D016601:RNA-Binding Proteins; D011994:Recombinant Proteins; C514824:reverse transcriptase, Human immunodeficiency virus 1; D054303:HIV Reverse Transcriptase
references.citation: Chembiochem. 2004 Oct 4;5(10):1432-47
references.pmid: 15457527
references.citation: J Virol. 1998 May;72(5):4116-26
references.pmid: 9557701
references.citation: Genes Dev. 2008 Jul 1;22(13):1804-15
references.pmid: 18593881
references.citation: Autoimmun Rev. 2006 May;5(5):299-305
references.pmid: 16782553
references.citation: Biochemistry. 2008 Dec 30;47(52):14020-7
references.pmid: 19067547
references.citation: J Biol Chem. 1996 Apr 5;271(14):8144-51
references.pmid: 8626503
references.citation: J Virol. 1995 Aug;69(8):5048-56
references.pmid: 7541845
references.citation: J Virol. 1996 Dec;70(12):8701-9
references.pmid: 8970997
references.citation: Science. 1992 Jun 26;256(5065):1783-90
references.pmid: 1377403
references.citation: J Magn Reson B. 1995 Jul;108(1):94-8
references.pmid: 7627436
references.citation: Cell. 2008 Oct 3;135(1):49-60
references.pmid: 18854154
references.citation: Neurology. 1995 Mar;45(3 Pt 1):544-50
references.pmid: 7898713
references.citation: Cell Host Microbe. 2008 Nov 13;4(5):495-504
references.pmid: 18976975
references.citation: J Biol Chem. 2005 Aug 12;280(32):29047-52
references.pmid: 15970587
references.citation: EMBO J. 1997 Mar 17;16(6):1224-35
references.pmid: 9135139
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2987-92
references.pmid: 14981256
references.citation: Retrovirology. 2008 Jun 10;5:47
references.pmid: 18544151
references.citation: Eur J Biochem. 1990 Jan 26;187(2):307-14
references.pmid: 1688798
references.citation: Nat Chem Biol. 2007 Aug;3(8):508-15
references.pmid: 17632515
references.citation: J Immunol. 1999 Oct 1;163(7):3653-61
references.pmid: 10490959
references.citation: J Biol Chem. 2009 May 15;284(20):13812-13822
references.pmid: 19246451
references.citation: J Infect Dis. 1991 Jan;163(1):78-82
references.pmid: 1984479
references.citation: J Biol Chem. 2007 Jul 20;282(29):20948-59
references.pmid: 17517897
references.citation: Methods Enzymol. 1995;262:130-44
references.pmid: 8594344
references.citation: Cell Cycle. 2008 Nov 1;7(21):3371-7
references.pmid: 18948743
references.citation: Science. 2008 Feb 15;319(5865):921-6
references.pmid: 18187620
references.citation: J Mol Biol. 2008 Nov 21;383(4):783-96
references.pmid: 18786546
references.citation: J Virol. 1999 Mar;73(3):2126-35
references.pmid: 9971795
references.citation: Gene. 1992 Nov 16;121(2):203-12
references.pmid: 1280240
references.citation: Lancet. 1989 May 27;1(8648):1206-7
references.pmid: 2566769
references.citation: J Virol. 2008 Feb;82(3):1425-37
references.pmid: 18045931
references.citation: J Virol. 1997 Sep;71(9):7080-2
references.pmid: 9261439